Pzena Investment Management’s United Therapeutics UTHR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,599	Closed	-$509K	–	166
2024 Q2	$509K	Sell	1,599 -498	-24%	-$132K	﹤0.01%	142
2024 Q1	$482K	Buy	2,097 +75	+4%	+$16.9K	﹤0.01%	143
2023 Q4	$445K	Buy	2,022 +159	+9%	+$36.6K	﹤0.01%	152
2023 Q3	$421K	Sell	1,863 -211	-10%	-$48.6K	﹤0.01%	147
2023 Q2	$458K	Buy	2,074 +369	+22%	+$81.7K	﹤0.01%	146
2023 Q1	$382K	Buy	+1,705	New	+$420K	﹤0.01%	150
2022 Q2	–	Sell	-2,768	Closed	-$497K	–	178
2022 Q1	$497K	Buy	2,768 +181	+7%	+$34.5K	﹤0.01%	152
2021 Q4	$559K	Sell	2,587 -209	-7%	-$41K	﹤0.01%	150
2021 Q3	$516K	Buy	2,796 +500	+22%	+$98.5K	﹤0.01%	150
2021 Q2	$412K	Buy	+2,296	New	+$437K	﹤0.01%	158
2021 Q1	–	Sell	-4,289	Closed	-$651K	–	182
2020 Q4	$651K	Sell	4,289 -804	-16%	-$106K	﹤0.01%	147
2020 Q3	$514K	Sell	5,093 -185	-4%	-$20.3K	﹤0.01%	156
2020 Q2	$639K	Buy	+5,278	New	+$594K	﹤0.01%	157